tiprankstipranks
Bg Medicine (BGMD)
OTHER OTC:BGMD
US Market
Holding BGMD?
Track your performance easily

BG Medicine (BGMD) Income Statement

17 Followers

BG Medicine Income Statement

Last quarter (Q ), BG Medicine's total revenue was $-4.96M, a decrease of -131.80% from the same quarter last year. In Q, BG Medicine's net income was $-3.09M. See BG Medicine’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 15Dec 14Dec 13
Total Revenue
$ 50.15M$ 50.15M$ 68.20M$ 1.57M$ 2.79M$ 4.07M
Cost of Revenue
$ 43.90M$ 43.90M$ 58.58M$ 505.00K$ 956.00K$ 1.39M
Gross Profit
$ 6.24M$ 6.24M$ 9.62M$ 1.06M$ 1.83M$ 2.68M
Operating Expense
$ 12.38M$ 12.38M$ 10.84M$ 5.69M$ 9.19M$ 17.06M
Operating Income
$ -6.14M$ -6.14M$ -1.23M$ -4.63M$ -7.36M$ -14.37M
Net Non Operating Interest Income Expense
$ 105.00K$ 105.00K$ 5.09M$ -159.00K$ -726.00K$ -1.15M
Other Income Expense
$ -3.14M$ -3.14M$ 3.73M$ -514.00K$ 24.00K$ -322.00K
Pretax Income
$ -4.73M$ -4.73M$ -2.59M$ -5.30M$ -8.06M$ -15.85M
Tax Provision
$ -2.22M$ -2.22M$ 125.00K---
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -2.65M$ -2.65M$ -1.15M$ -6.96M$ -8.06M$ -15.85M
Basic EPS
$ -19.21$ -19.21$ -0.01$ -0.72$ -1.00$ -2.32
Diluted EPS
$ -0.02$ -0.02$ -0.01$ -0.72$ -1.00$ -2.32
Basic Average Shares
$ 275.92M$ 137.82K$ 135.42M$ 9.61M$ 8.18M$ 6.80M
Diluted Average Shares
$ 278.01M$ 137.82K$ 135.42M$ 9.61M$ 8.18M$ 6.80M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 56.29M$ 56.29M$ -69.42M$ 6.20M$ 10.15M$ 18.45M
Interest Expense
---$ 159.00K$ 728.00K$ 1.17M
Net Income From Continuing And Discontinued Operation
$ -2.65M$ -2.65M$ -1.15M$ -5.30M$ -8.06M$ -15.85M
Normalized Income
$ -4.20M$ -6.95M-$ -4.79M$ -8.09M$ -15.53M
EBIT
$ -4.83M$ -4.83M$ -7.68M$ -5.14M$ -7.34M$ -14.68M
EBITDA
---$ -5.06M$ -7.21M$ -14.52M
Currency in USD

BG Medicine Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis